
|Podcasts|September 16, 2021
Dr. Seth assesses the bleeding risk of Botox treatments in patients who take blood thinners
Author(s)Urology Times staff
“We're not saying a blanket stop for all patients, but I think we do need to be taking each patient as an individual in terms of their backgrounds,” says Jai Seth, MD.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Jai Seth, MD. He discusses onabotulinumtoxinA injection programs as a treatment for urinary incontinence and the bleeding risk associated with these injections for patients who also take blood thinners. Seth is a consultant urological surgeon at St. George’s University hospital, London, UK.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
AI-generated profiles impersonate female urologists to market ED products online
2
Alternative BCG strains may help address ongoing supply challenges in NMIBC
3
Doublet or triplet? Urologists weighs in on mCSPC options
4
Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA
5






